Anna Skálová
- Molecular Medicine top 2%
- Endocrinology top 5%
- Molecular Biology
- Pollution top 10%
- Clinical Biochemistry top 10%
- Co-authors
- Kateřina ChudějováJaroslav HrabákCostas C. PapagiannitsisMatej MedveckýVladislav JakubůHelena ŽemličkováTamara BergerováIbrahim Bitar
- Topics
- Antibiotic Resistance in Bacteria (7 papers)Enterobacteriaceae and Cronobacter Research (4 papers)Bacterial Identification and Susceptibility Testing (2 papers)
- Partner nations
- CzechiaNetherlandsPoland
In The Last Decade
Anna Skálová
12 papers receiving 317 citations
Peers
Comparison fields: 5 of 45
- Molecular Medicine 254
- Endocrinology 135
- Molecular Biology 83
- Pollution 65
- Clinical Biochemistry 52
Countries citing papers authored by Anna Skálová
This map shows the geographic impact of Anna Skálová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Skálová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Skálová more than expected).
Fields of papers citing papers by Anna Skálová
This network shows the impact of papers produced by Anna Skálová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Skálová. The network helps show where Anna Skálová may publish in the future.
Co-authorship network of co-authors of Anna Skálová
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Skálová. A scholar is included among the top collaborators of Anna Skálová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Skálová. Anna Skálová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 57 | |
| 3 | 12 | |
| 4 | 33 | |
| 5 | 28 | |
| 6 | 10 | |
| 7 | 10 | |
| 8 | 48 | |
| 9 | 61 | |
| 10 | 25 | |
| 11 | Kvalita života osob s demencí v domácí a institucionální péči | 0 |
| 12 | The importance of prognostic factors in premenopausal women with breast cancer. | 21 |
| 13 | [Fixation and decalcification in trephination biopsy]. | 1 |
About Anna Skálová
Anna Skálová is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry, having authored 13 papers that have together received 319 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Enterobacteriaceae and Cronobacter Research (4 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Molecular Medicine (254 citations), Endocrinology (135 citations) and Applied Microbiology and Biotechnology (26 citations). Anna Skálová has collaborated with scholars based in Czechia, Netherlands and Poland. Frequent co-authors include Kateřina Chudějová, Jaroslav Hrabák, Costas C. Papagiannitsis, Matej Medvecký, Vladislav Jakubů, Helena Žemličková, Tamara Bergerová, Ibrahim Bitar, Eva Chudáčková and Vendula Študentová. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.